We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.36%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
QIM
376
Quantitative Investment Management
Virginia
$3.9M -$476K -2,300 -12%
ACM
377
Alta Capital Management
Utah
$3.88M +$271K +1,307 +8%
CCM
378
Cobalt Capital Management
New Jersey
$3.88M -$24.4M -117,700 -87%
CBB
379
Citizens Business Bank
California
$3.87M -$73.3K -354 -2%
KCM
380
Kornitzer Capital Management
Kansas
$3.75M -$6.45M -31,168 -65%
EP
381
Edgestream Partners
New Jersey
$3.75M +$3.48M +16,795 New
ICRM
382
Insight Capital Research & Management
California
$3.73M +$3.46M +16,712 New
TPCM
383
Three Peaks Capital Management
Colorado
$3.69M +$176K +849 +5%
SI
384
Shaker Investments
Ohio
$3.66M +$3.4M +16,419 New
TI
385
Turner Investments
Pennsylvania
$3.46M -$14.5M -70,031 -82%
DAM
386
Deltec Asset Management
New York
$3.46M +$3.21M +15,500 New
GIM
387
Groesbeck Investment Management
New Jersey
$3.45M +$1.25M +6,035 +64%
Robeco Institutional Asset Management
388
Robeco Institutional Asset Management
Netherlands
$3.44M +$3.19M +15,410 New
CI
389
Chartist Inc
California
$3.39M -$28.8K -139 -0.9%
WB
390
WesBanco Bank
West Virginia
$3.39M -$71.4K -345 -2%
BOH
391
Bank of Hawaii
Hawaii
$3.38M +$562K +2,714 +22%
Group One Trading
392
Group One Trading
Illinois
$3.38M +$1.89M +9,124 +152%
CCM
393
Catapult Capital Management
New York
$3.35M +$2.71M +13,092 +686%
MCM
394
Mazama Capital Management
Oregon
$3.34M +$3.04M +14,669 +5,093%
SFP
395
Santa Fe Partners
New Mexico
$3.33M +$3.09M +14,945 New
HCM
396
Hayman Capital Management
Texas
$3.3M +$3.06M +14,800 New
SLI
397
Sumitomo Life Insurance
Japan
$3.29M +$1M +4,831 +49%
SCM
398
Stux Capital Management
New York
$3.28M -$932K -4,500 -23%
ANBT
399
American National Bank & Trust
Texas
$3.26M -$3.73K -18 -0.1%
LSERS
400
Louisiana State Employees Retirement System
Louisiana
$3.25M +$163K +785 +6%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.